Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations.
about
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice.Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirinCharacterization of HIV-1 Resistance to Tenofovir Alafenamide In Vitro.Drug resistance and antiretroviral drug development.Rationale and uses of a public HIV drug-resistance databaseAptamers that recognize drug-resistant HIV-1 reverse transcriptaseTargeting of the purine biosynthesis host cell pathway enhances the activity of tenofovir against sensitive and drug-resistant HIV-1A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors.Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirineHuman immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibility.Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.Indirubin 3'-monoxime, from a Chinese traditional herbal formula, suppresses viremia in humanized mice infected with multidrug-resistant HIV
P2860
Q35910232-6165C214-B723-4EBC-872B-EF8B78C1684AQ35941302-11145668-C3D3-4F62-B26C-6EB90D95ED99Q36076011-01FB5CBF-5300-4F0D-A8B3-D2A260B8117CQ36104277-CD6F961A-10CB-4060-9947-0C1BC6035A45Q36572115-D78E95D7-9CC4-4156-AC88-B9388E05E367Q36986716-E046C429-F26A-4F9E-896C-11670CA4187BQ37332192-CBA980A4-3C08-49C9-AC2E-845948606492Q40142694-686736E7-6010-44D1-AB6E-D47E792D9959Q40288242-772240A8-24E7-45DC-973C-C8C4610B9B26Q41807080-59C230FF-CCDF-4255-B5B4-B2ECA930F139Q41822419-905609CF-33C5-4A2E-ACC6-211E8EB5B564Q42549637-7FA1C365-C009-4418-8CCF-8623A143A195Q42554535-542C3738-447E-47E5-AE6C-D04F44E5355F
P2860
Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Panel of prototypical infectio ...... nhibitor resistance mutations.
@en
type
label
Panel of prototypical infectio ...... nhibitor resistance mutations.
@en
prefLabel
Panel of prototypical infectio ...... nhibitor resistance mutations.
@en
P2093
P2860
P1433
P1476
Panel of prototypical infectio ...... nhibitor resistance mutations.
@en
P2093
Elizabeth Johnston
Kathryn M Dupnik
Mark A Winters
Matthew J Gonzales
Robert W Shafer
Soo-Yon Rhee
Tomozumi Imamichi
P2860
P304
P356
10.1097/01.AIDS.0000166098.54564.0C
P407
P577
2005-04-01T00:00:00Z